Brief: Bioarctic AB Says Eisai Expects Leqembi Sales To Reach JPY 42.5 Billion for FY.
08/11/2024 04:04
Nov 7 (Reuters) - Eisai Co Ltd 4523.T :
* BIOARCTIC AB - EISAI UPDATES LEQEMBI OUTLOOK FOR FISCAL
YEAR
2024 (APRIL 2024 - MARCH 2025). SALES NOW EXPECTED TO REACH JPY
42.5 BILLION
Source text: ID:nWkr9g48w
Further company coverage: 4523.T
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BioArctic AB (publ)
See all newsBrief: BioArctic Gets Leqembi Pen Subcutaneous Formulation Approval In Japan
Brief: BioArctic Says Leqembi Subcutaneous Formulation Approved For Initiation Treatment In China
Brief: BioArctic Says Canada's Drug Agency Issues Final Positive Recommendation Supporting Public Reimbursement Of Leqembi
Sweden's BioArctic Q2 revenue falls despite higher Leqembi royalties
Brief: BioArctic Q2 Net Sales Down At SEK 247.5 Mln